IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
暂无分享,去创建一个
Michael G. Kharas | C. Leslie | S. Armstrong | Sun-Mi Park | E. Shevach | M. Kharas | A. Krivtsov | Arthur Chow | James Taggart | T. Chou | Lauren Fairchild | S. Chhangawala | Hyunwoo Cho | M. Witkin | J. H. Kim | A. Thornton | Antoine Gruet | T. Barlowe | Alexandria Schurer | S. Armstrong
[1] S. Henikoff,et al. Targeted in situ genome-wide profiling with high efficiency for low cell numbers , 2018, Nature Protocols.
[2] C. Benoist,et al. Different molecular complexes that mediate transcriptional induction and repression by FoxP3 , 2017, Nature Immunology.
[3] Michael R. Green,et al. An Embryonic Stem Cell-Specific NuRD Complex Functions through Interaction with WDR5 , 2017, Stem cell reports.
[4] Sun Mi Park,et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells , 2017, Nature Genetics.
[5] C. Mullighan,et al. Genetic Basis of Acute Lymphoblastic Leukemia. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Steven Henikoff,et al. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites , 2016, bioRxiv.
[7] W. Liu,et al. Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia , 2016, PloS one.
[8] C. Leslie,et al. Memory of Inflammation in Regulatory T Cells , 2016, Cell.
[9] CT Collins,et al. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets , 2016, Oncogene.
[10] S. Armstrong,et al. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia. , 2015, Cell stem cell.
[11] T. Holderried,et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios , 2015, Science.
[12] Christina S. Leslie,et al. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation , 2015, Nature Genetics.
[13] G. Hardiman,et al. Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia. , 2015, Cell stem cell.
[14] Michael G. Kharas,et al. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. , 2015, The Journal of clinical investigation.
[15] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[16] S. Carr,et al. Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells , 2014, Science.
[17] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[18] S. Ogawa,et al. Adult T‐cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth , 2013, Cancer science.
[19] P. Witkowski,et al. FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells. , 2013, International immunopharmacology.
[20] B. Bernstein,et al. Epigenetic Reprogramming in Cancer , 2013, Science.
[21] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[22] James B. Brown,et al. Sparse linear modeling of next-generation mRNA sequencing (RNA-Seq) data for isoform discovery and abundance estimation , 2011, Proceedings of the National Academy of Sciences.
[23] A. Melnick,et al. The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation , 2011, Science.
[24] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[25] William Stafford Noble,et al. FIMO: scanning for occurrences of a given motif , 2011, Bioinform..
[26] Y. Belkaid,et al. Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.
[27] I. Weissman,et al. Evaluation of the Long‐Term Reconstituting Subset of Hematopoietic Stem Cells with CD150 , 2009, Stem cells.
[28] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[29] Robert Gentleman,et al. rtracklayer: an R package for interfacing with genome browsers , 2009, Bioinform..
[30] Richard A Young,et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. , 2008, Genes & development.
[31] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[32] Edgar Wingender,et al. The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation , 2008, Briefings Bioinform..
[33] E. Passegué,et al. MicroRNA-126 Regulates HOXA9 by Binding to the Homeobox , 2008, Molecular and Cellular Biology.
[34] Satoshi Tanaka,et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.
[35] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[36] S. Smale,et al. Predominant Interaction of Both Ikaros and Helios with the NuRD Complex in Immature Thymocytes* , 2007, Journal of Biological Chemistry.
[37] J. Downing,et al. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias , 2007, Leukemia.
[38] J. Bates,et al. Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. , 2007, Blood.
[39] M. Tanimoto,et al. Characterization of the short isoform of Helios overexpressed in patients with T‐cell malignancies , 2007, Cancer science.
[40] M. Cleary,et al. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells. , 2006, Cancer cell.
[41] Hartmut Döhner,et al. Acute myeloid leukaemia , 2006, The Lancet.
[42] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[43] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Guertin,et al. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.
[46] Y. Honma,et al. Induction of CCAAT/enhancer binding protein‐δ by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells , 2005, British journal of haematology.
[47] J. Hess. MLL: a histone methyltransferase disrupted in leukemia. , 2004, Trends in molecular medicine.
[48] S. Korsmeyer,et al. Definitive hematopoiesis requires the mixed-lineage leukemia gene. , 2004, Developmental cell.
[49] A. Rebollo,et al. Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignancies , 2003, Immunology and cell biology.
[50] D. Ramji,et al. CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.
[51] Barbara Hoffman,et al. The proto-oncogene c-myc in hematopoietic development and leukemogenesis , 2002, Oncogene.
[52] M. Manns,et al. Autoregulation enables different pathways to control CCAAT/enhancer binding protein β (C/EBPβ) transcription , 2001 .
[53] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[54] M. Krzywinski,et al. New insights to the MLL recombinome of acute leukemias , 2009, Leukemia.
[55] Alexander E. Kel,et al. TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..